1 |
Henson P.M., D.L. Bratton, V.A. Fadok 2001. Apoptotic cell removal. Curr. Biol. 11, R795-805
DOI
ScienceOn
|
2 |
Idriss H.T., J.H. Naismith 2000. TNF alpha and the TNF receptor superfamily: structure-function relationship(s), Microsc. Res. Tech. 50, 184-195
DOI
ScienceOn
|
3 |
Kockx M.M., A.G. Herman 1998. Apoptosis in atherogenesis: implications for plaque destabilization. Eur. Heart J. 19 Suppl G, G23-28
|
4 |
Kockx M.M., A.G. Herman 2000. Apoptosis in atherosclerosis: beneficial or detrimental? Cardiovasc. Res. 45, 736-746
DOI
ScienceOn
|
5 |
Libby P. 2001. Current concepts of the pathogenesis of the acute coronary syndromes. Circulation 104, 365-372
DOI
ScienceOn
|
6 |
MacEwan D.J. 2002. TNF ligands and receptors-a matter of life and death. Br. J. Pharmacol. 135, 855-875
DOI
ScienceOn
|
7 |
Nagata S. 1999. Fas ligand-induced apoptosis. Annu. Rev. Genet. 33, 29-55
DOI
ScienceOn
|
8 |
Proudfoot D., J.N. Skepper, L. Hegyi, M.R. Bennett, C.M. Shanahan, P.L. Weissberg 2000. Apoptosis regulates human vascular calcification in vitro: evidence for initiation of vascular calcification by apoptotic bodies. Circ. Res. 87, 1055-1062
DOI
ScienceOn
|
9 |
Schaub F.J., D.K. Han, W.C. Liles 2000. Fas/FADD-mediated activation of a specific program of inflammatory gene expression in vascular smooth muscle cells. Nat. Med. 6, 790-796
DOI
ScienceOn
|
10 |
Vaux D.L., S.J. Korsmeyer 1999. Cell death in development. Cell 96, 245-254
DOI
ScienceOn
|
11 |
Walsh C.M., B.G. Wen, A.M. Chinnaiyan, K. O'Rourke, V.M. Dixit, S.M. Hedrick 1998. A role for FADD in T cell activation and development. Immunity 8, 439-449
DOI
ScienceOn
|
12 |
Baker S.J., E.P. Reddy 1998. Modulation of life and death by the TNF receptor superfamily. Oncogene 17, 3261-3270
DOI
|
13 |
Bauriedel G., R. Hutter, U. Welsch, R. Bach, H. Sievert, B. Luderitz 1999. Role of smooth muscle cell death in advanced coronary primary lesions: implications for plaque instability. Cardiovasc. Res. 41, 480-488
DOI
ScienceOn
|
14 |
Bennett M.R. 1999. Apoptosis of vascular smooth muscle cells in vascular remodelling and atherosclerotic plaque rupture. Cardiovasc. Res. 41, 361-368
DOI
ScienceOn
|
15 |
Biancone L., A.D. Martino, V. Orlandi, P.G. Conaldi, A. Toniolo, G. Camussi 1997. Development of inflammatory angiogenesis by local stimulation of Fas in vivo. J. Exp Med. 186, 147-152
DOI
ScienceOn
|
16 |
Chinnaiyan A.M, V.M Dixit 1996. The cell-death machine. Curr. Biol. 6, 555-562
DOI
ScienceOn
|
17 |
Chinnaiyan A.M., K. O'Rourke, M. Tewari, V.M. Dixit 1995. FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis, Cell 81, 505-512
DOI
ScienceOn
|
18 |
Cho A., D.W. Courtman, B.L. Langille 1995. Apoptosis (programmed cell death) in arteries of the neonatal lamb. Circ. Res. 76, 168-175
DOI
ScienceOn
|
19 |
Crisby M., B. Kallin, J. Thyberg 1997. Cell death in human atherosclerotic plaques involves both oncosis and apoptosis. Atherosclerosis 130, 17-27
DOI
ScienceOn
|
20 |
Flynn P.D., C.D. Byrne, T.P. Baglin, P.L. Weissberg, M.R. Bennett 1997. Thrombin generation by apoptotic vascular smooth muscle cells. Blood 89, 4378-4384
|
21 |
Kockx M.M. 1998. Apoptosis in the atherosclerotic plaque: quantitative and qualitative aspects. Arterioscler. Thromb. Vasc. Biol. 18, 1519-1522
DOI
ScienceOn
|
22 |
Chinnaiyan A.M., C.G. Tepper, M.F. Seldin 1996. FADD/MORT1 is a common mediator of CD 95 (Fas/APO-1) and tumor necrosis factor receptor-induced apoptosis. J. Biol. Chem. 271, 4961-4965
DOI
|